Patent · US Active

IRAK inhibitors and uses thereof

US9751892B2 · kind B2 · utility

4Cited by
10References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 17, 2015
Grant dateSep 5, 2017
Priority date
Expiry dateSep 17, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.